Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.58 |
| ▸ | NAAA | Q02083 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | RECQL | P46063 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 3/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | CA7 | P43166 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | IDO1 | P14902 | 1/20 | 0.43 |
| ▸ | LTA4H | P09960 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Triethylene Glycol SCHEMBL29103842 | 1.00 | TSHR (0.58) | TSHRNAAAKDM4EPOLBMEN1 | |
| SCHEMBL24748 | 1.00 | TSHR (0.58) | TSHRNAAAKDM4EPOLBMEN1 | |
| SCHEMBL607716 | 1.00 | TSHR (0.58) | TSHRNAAAKDM4EPOLBMEN1 | |
| SCHEMBL16437096 | 1.00 | TSHR (0.58) | TSHRNAAAKDM4EPOLBMEN1 | |
| SCHEMBL599527 | 1.00 | TSHR (0.58) | TSHRNAAAKDM4EPOLBMEN1 | |
| SCHEMBL607698 | 1.00 | TSHR (0.58) | TSHRNAAAKDM4EPOLBMEN1 | |
| SCHEMBL12865302 | 1.00 | TSHR (0.58) | TSHRNAAAKDM4EPOLBMEN1 | |
| SCHEMBL3552086 | 1.00 | TSHR (0.58) | TSHRNAAAKDM4EPOLBMEN1 | |
| SCHEMBL16437099 | 1.00 | TSHR (0.58) | TSHRNAAAKDM4EPOLBMEN1 | |
| SCHEMBL851320 | 1.00 | TSHR (0.58) | TSHRNAAAKDM4EPOLBMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 112 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111589420-A | Millimeter-grade macroporous-mesoporous carbon sphere/cup [4] -double crown-6 interpenetrating composite material and preparation method and application thereof | 东华理工大学 | 2020-08-28 | — | — | CN | claimed |
| US-20260124309-A1 | STAT6 DEGRADERS AND USES THEREOF | KYMERA THERAPEUTICS INC (US) | 2026-05-07 | — | — | US | disclosed |
| US-12559486-B2 | Tau-protein targeting compounds and associated methods of use | ARVINAS OPERATIONS, INC. (US) | 2026-02-24 | — | — | US | disclosed |
| US-20250325673-A1 | IRAK DEGRADERS AND USES THEREOF | KYMERA THERAPEUTICS INC (US) | 2025-10-23 | — | — | US | disclosed |
| EP-4613773-A2 | IRAK DEGRADERS AND USES THEREOF | Kymera Therapeutics, Inc. (US) | 2025-09-10 | — | — | EP | disclosed |
| EP-3731869-B1 | IRAK DEGRADERS AND USES THEREOF | KYMERA THERAPEUTICS INC (US) | 2025-07-23 | — | — | EP | disclosed |
| CN-118791368-B | Method for preparing high-purity monodisperse polyethylene glycol derivative | 陕西师范大学 | 2025-06-10 | — | — | CN | disclosed |
| US-20250161459-A1 | TRKB LIGAND CONJUGATED COMPOUNDS AND USES THEREOF | ADARX PHARMACEUTICALS, INC. (US) | 2025-05-22 | — | — | US | disclosed |
| CN-119954801-A | TAU protein targeting compounds and related methods of use | 阿尔维纳斯运营股份有限公司 | 2025-05-09 | — | — | CN | disclosed |
| WO-2025049820-A1 | STAT6 DEGRADERS AND USES THEREOF | KYMERA THERAPEUTICS, INC. (US) | 2025-03-06 | — | — | WO | disclosed |
| EP-1553412-A1 | METHOD OF INHIBITING NONSPECIFIC INTERACTION BETWEEN MOLECULES ON SOLID PHASE SUPPORT | Reverse Proteomics Research Institute Co., Ltd (JP) | 2005-07-13 | — | — | EP | disclosed |
| US-6887837-B2 | Water-based paint-removing solution | HENKEL KOMMANDIRGESELLSCHAFT AUF AKTIEN (DE) | 2005-05-03 | — | — | US | disclosed |
| US-20040259753-A1 | Water-based flushing solution for paints and other coatings | HENKEL AG & CO. KGAA (DE) | 2004-12-23 | — | — | US | disclosed |
| US-20040127375-A1 | Coating removal compositions | HENKEL AG & CO. KGAA (DE) | 2004-07-01 | — | — | US | disclosed |
| US-20040084373-A1 | Adding chemical(s) to treatment vessel; separating aggregated compounds; directing to sprayer; solution contains amine and/or alkanolamine, polyoxypropylene glyocl, alkoxyethanol, and water | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2004-05-06 | — | — | US | disclosed |
| EP-1375606-A2 | Flushing solutions for coatings removal | Henkel KGaA (DE) | 2004-01-02 | — | — | EP | disclosed |
| US-20040002437-A1 | Flushing solutions for coatings removal | HENKEL AG & CO. KGAA (DE) | 2004-01-01 | — | — | US | disclosed |
| EP-1348042-A1 | WATER-BASED PAINT-REMOVING SOLUTION | Henkel Kommanditgesellschaft auf Aktien (DE) | 2003-10-01 | — | — | EP | disclosed |
| US-20020144718-A1 | Water-based paint-removing solution | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2002-10-10 | — | — | US | disclosed |
| WO-2002053802-A1 | WATER-BASED PAINT-REMOVING SOLUTION | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2002-07-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250325673-A1 | IRAK DEGRADERS AND USES THEREOF | IRAK2, IRAK3, IRAK1 | TSHR 3319/4885NAAA 1342/4885KDM4E 190/4885 |
| US-20260124309-A1 | STAT6 DEGRADERS AND USES THEREOF | STAT6, NCOR2, NCOR1 | TSHR 70/4885NAAA 3147/4885KDM4E 1888/4885 |
| US-20250161459-A1 | TRKB LIGAND CONJUGATED COMPOUNDS AND USES THEREOF | NTRK2, NTRK1, BDNF | TSHR 208/4885NAAA 2617/4885KDM4E 3416/4885 |
| US-12559486-B2 | Tau-protein targeting compounds and associated methods of use | UBQLN2, UBQLN1, CRBN | TSHR 2915/4885NAAA 4780/4885KDM4E 525/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.